GlassScriptPhysician profile
Neilda Erickson
NPI 1548993181
$615.86
in general payments reported to CMS, 2019-2025
10 companies · $42.09 in 2025
The $42.09 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $147 · 2023: $150 · 2024: $277 · 2025: $42.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $130.06 | 2024 | |
| Integra Lifesciences Corporation | $99.40 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $98.84 | 2024 | Apligraf |
| Orthofix Medical, INC. | $77.43 | 2022 | |
| Smith+Nephew, INC. | $54.69 | 2022-2023 | Pico 7, Renasys Go V2 Home, Collagenase Santyl |
| Bayer Healthcare Pharmaceuticals INC. | $47.71 | 2022 | |
| Depuy Synthes Sales INC. | $42.09 | 2025 | Minibunion |
| Solventum Corporation | $27.80 | 2024 | Activ.A.C. |
| Kairos Surgical INC | $20.41 | 2024 | |
| Bioventus LLC | $17.43 | 2023 | Sonicone Clinic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neilda Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.